» Authors » J P H Shield

J P H Shield

Explore the profile of J P H Shield including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 32
Citations 688
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Mears R, Salway R, Sharp D, Shield J, Jago R
BMC Public Health . 2020 Dec; 20(1):1902. PMID: 33302899
Background: This paper aims to explore change in BMI z-score through childhood and the association between parent BMI and child BMI z-score. This is important to understand for the development...
2.
Candler T, Mahmoud O, Lynn R, Majbar A, Barrett T, Shield J
Diabet Med . 2018 Feb; 35(6):737-744. PMID: 29460341
Aims: To estimate the incidence of Type 2 diabetes in children aged <17 years, compare this with similar data 10 years ago, and characterize clinical features at diagnosis in the...
3.
White B, Jamieson L, Clifford S, Shield J, Christie D, Smith F, et al.
Clin Obes . 2015 May; 5(3):116-26. PMID: 25974187
Only two anti-obesity drugs (AODs) are frequently prescribed in paediatric obesity, orlistat and metformin. Meta-analyses show modest benefit in clinical trials, yet analyses of prescribing databases show high levels of...
4.
Turner K, Percival J, Dunger D, Olbers T, Barrett T, Shield J
Diabet Med . 2014 Sep; 32(2):250-6. PMID: 25186101
Aim: To explore adolescents' views and experiences of different treatments for Type 2 diabetes, in order to improve treatment concordance and consider how the current treatment pathway for adolescent Type...
5.
Williams G, Bredow M, Barton J, Pryce R, Shield J
Arch Dis Child . 2013 Nov; 99(3):297-9. PMID: 24225275
Article nine of the UN Convention of the Rights of the Child states that 'Children must not be separated from their parents unless it is in the best interests of...
6.
Docherty L, Kabwama S, Lehmann A, Hawke E, Harrison L, Flanagan S, et al.
Diabetologia . 2013 Feb; 56(4):758-62. PMID: 23385738
Aims/hypothesis: 6q24 transient neonatal diabetes mellitus (TNDM) is a rare form of diabetes presenting in the neonatal period that remits during infancy but, in a proportion of cases, recurs in...
7.
Cuenca-Garcia M, Jago R, Shield J, Burren C
Diabet Med . 2012 Jul; 29(10):e369-76. PMID: 22803800
Aims: To assess physical activity and fitness levels of young people with Type 1 diabetes compared with siblings without diabetes, and to investigate the association between physical activity, physical fitness...
8.
Galhardo J, Hunt L, Shield J
Diabet Med . 2012 Feb; 29(7):e117-20. PMID: 22288782
Introduction: Circulating pigment epithelium-derived factor, or serine protease inhibitor F1, is upregulated during adipogenesis, contributing to obesity-induced insulin resistance. Furthermore, pigment epithelium-derived factor is abundant in stage I melanosomes and...
9.
Galhardo J, Hunt L, Lightman S, Sabin M, Bergh C, Sodersten P, et al.
J Clin Endocrinol Metab . 2011 Dec; 97(2):E193-201. PMID: 22162463
Hypothesis: Retraining obese adolescents to eat more slowly will lead to beneficial changes in circulating concentrations of gastrointestinal satiety hormones. Methods: Ghrelin and peptide tyrosine-tyrosine were measured during an oral...
10.
Sabin M, Magnussen C, Juonala M, Cowley M, Shield J
Pharmacol Res . 2011 Nov; 65(4):397-401. PMID: 22037094
The metabolic syndrome (MetS) is defined as a clustering of risk factors predisposing to the future development of cardiovascular disease and Type 2 diabetes mellitus (T2DM). Its clinical relevance, above...